awmsg logo



bilastine (Ilaxten®)


Reference No. 1068

Publication date:
13/10/2011


Appraisal information

bilastine (Ilaxten®) 20 mg tablet


Company: A. Menarini Farmaceutica Internazionale SRL
BNF category: Respiratory system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 11/10/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, bilastine (Ilaxten®) cannot be endorsed for use within NHS Wales for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Statement of Advice (SOA)
Download